We've found
15,419
archived clinical trials in
Pulmonary
We've found
15,419
archived clinical trials in
Pulmonary
Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Updated: 1/26/2018
A Multi-Center, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity of Aerosolized ALN-RSV01 Plus Standard of Care in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Status: Enrolling
Updated: 1/26/2018
Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Updated: 1/26/2018
A Multi-Center, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity of Aerosolized ALN-RSV01 Plus Standard of Care in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Status: Enrolling
Updated: 1/26/2018
Click here to add this to my saved trials
Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Updated: 1/26/2018
A Multi-Center, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity of Aerosolized ALN-RSV01 Plus Standard of Care in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Status: Enrolling
Updated: 1/26/2018
Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Updated: 1/26/2018
A Multi-Center, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity of Aerosolized ALN-RSV01 Plus Standard of Care in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Status: Enrolling
Updated: 1/26/2018
Click here to add this to my saved trials
Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Updated: 1/26/2018
A Multi-Center, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity of Aerosolized ALN-RSV01 Plus Standard of Care in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Status: Enrolling
Updated: 1/26/2018
Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Updated: 1/26/2018
A Multi-Center, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity of Aerosolized ALN-RSV01 Plus Standard of Care in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Status: Enrolling
Updated: 1/26/2018
Click here to add this to my saved trials
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial
Status: Enrolling
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial
Status: Enrolling
Updated: 1/27/2018
Click here to add this to my saved trials
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial
Status: Enrolling
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial
Status: Enrolling
Updated: 1/27/2018
Click here to add this to my saved trials
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial
Status: Enrolling
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial
Status: Enrolling
Updated: 1/27/2018
Click here to add this to my saved trials
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial
Status: Enrolling
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial
Status: Enrolling
Updated: 1/27/2018
Click here to add this to my saved trials
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial
Status: Enrolling
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial
Status: Enrolling
Updated: 1/27/2018
Click here to add this to my saved trials
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial
Status: Enrolling
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial
Status: Enrolling
Updated: 1/27/2018
Click here to add this to my saved trials
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial
Status: Enrolling
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation
Updated: 1/27/2018
Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial
Status: Enrolling
Updated: 1/27/2018
Click here to add this to my saved trials
Non-rebreather at Flush Rate Compared to Bag Valve Mask With Assist
Status: Enrolling
Updated: 1/28/2018
Updated: 1/28/2018
Non-rebreather at Flush Rate Compared to Bag Valve Mask With Assist
Status: Enrolling
Updated: 1/28/2018
Updated: 1/28/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Third International Study on Mechanical Ventilation
Updated: 2/1/2018
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Urinary Leukotriene E4 Levels in Children With Obstructive Sleep Apnea
Updated: 2/2/2018
Urinary Leukotriene E4 Levels in Children With Obstructive Sleep Apnea
Status: Enrolling
Updated: 2/2/2018
Urinary Leukotriene E4 Levels in Children With Obstructive Sleep Apnea
Updated: 2/2/2018
Urinary Leukotriene E4 Levels in Children With Obstructive Sleep Apnea
Status: Enrolling
Updated: 2/2/2018
Click here to add this to my saved trials
Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe CF
Updated: 2/5/2018
Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe Cystic Fibrosis Lung Disease
Status: Enrolling
Updated: 2/5/2018
Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe CF
Updated: 2/5/2018
Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe Cystic Fibrosis Lung Disease
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Updated: 2/6/2018
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials